BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29187490)

  • 1. A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Cancer Patients with Arterial Involvement.
    Masui T; Takaori K; Anazawa T; Sato A; Nakano K; Uchida Y; Yogo A; Goto Y; Matsumoto S; Kodama Y; Kanai M; Isoda H; Mizumoto M; Kawaguchi Y; Shibuya K; Itasaka S; Uemoto S
    Anticancer Res; 2017 Dec; 37(12):7023-7030. PubMed ID: 29187490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution.
    Masui T; Nagai K; Anazawa T; Sato A; Uchida Y; Nakano K; Yogo A; Kaneda A; Nakamura N; Yoshimura M; Mizowaki T; Uza N; Fukuda A; Matsumoto S; Kanai M; Isoda H; Mizumoto M; Seo S; Hata K; Taura K; Kawaguchi Y; Takaori K; Uemoto S; Hatano E
    BMC Cancer; 2022 Jan; 22(1):119. PubMed ID: 35093003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
    Ito M; Kodaira T; Tachibana H; Tomita N; Makita C; Koide Y; Kato D; Abe T; Muro K; Tajika M; Niwa Y; Hasegawa Y
    Head Neck; 2017 Dec; 39(12):2406-2415. PubMed ID: 28960561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma.
    Chapman BC; Gleisner A; Rigg D; Meguid C; Goodman K; Brauer B; Gajdos C; Schulick RD; Edil BH; McCarter MD
    J Surg Oncol; 2018 Apr; 117(5):1073-1083. PubMed ID: 29448308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients.
    Huang X; Knoble JL; Zeng M; Aguila FN; Patel T; Chambers LW; Hu H; Liu H
    PLoS One; 2016; 11(12):e0166606. PubMed ID: 27935952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
    DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer planning: Complex conformal vs modulated therapies.
    Chapman KL; Witek ME; Chen H; Showalter TN; Bar-Ad V; Harrison AS
    Med Dosim; 2016; 41(2):100-4. PubMed ID: 26831922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer.
    Prasad S; Cambridge L; Huguet F; Chou JF; Zhang Z; Wu AJ; O'Reilly EM; Allen PJ; Goodman KA
    Pract Radiat Oncol; 2016; 6(2):78-85. PubMed ID: 26577010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
    Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of radiation techniques in treatment of oropharynx cancer.
    Rusthoven KE; Raben D; Ballonoff A; Kane M; Song JI; Chen C
    Laryngoscope; 2008 Apr; 118(4):635-9. PubMed ID: 18176348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer.
    Kharofa J; Tsai S; Kelly T; Wood C; George B; Ritch P; Wiebe L; Christians K; Evans DB; Erickson B
    Radiother Oncol; 2014 Oct; 113(1):41-6. PubMed ID: 25443499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing outcomes of stereotactic body radiotherapy with intensity-modulated radiotherapy for patients with locally advanced unresectable pancreatic cancer.
    Lin JC; Jen YM; Li MH; Chao HL; Tsai JT
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):259-64. PubMed ID: 25629569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer.
    Freilich J; Hoffe SE; Almhanna K; Dinwoodie W; Yue B; Fulp W; Meredith KL; Shridhar R
    Dis Esophagus; 2015; 28(4):352-7. PubMed ID: 24635657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.
    Boda-Heggemann J; Hofheinz RD; Weiss C; Mennemeyer P; Mai SK; Hermes P; Wertz H; Post S; Massner B; Hieber U; Hochhaus A; Wenz F; Lohr F
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1187-95. PubMed ID: 19409725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
    Minn AY; Hsu A; La T; Kunz P; Fisher GA; Ford JM; Norton JA; Visser B; Goodman KA; Koong AC; Chang DT
    Cancer; 2010 Aug; 116(16):3943-52. PubMed ID: 20564136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
    Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated and image-guided radiotherapy in patients with locally advanced inoperable pancreatic cancer after preradiation chemotherapy.
    Sinn M; Ganeshan R; Graf R; Pelzer U; Stieler JM; Striefler JK; Bahra M; Wust P; Riess H
    ScientificWorldJournal; 2014; 2014():452089. PubMed ID: 25401140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study.
    Naik A; Gurjar OP; Gupta KL; Singh K; Nag P; Bhandari V
    Cancer Radiother; 2016 Jul; 20(5):370-6. PubMed ID: 27368915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters.
    Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Tamari K; Yamashita M; Unno H; Kinose Y; Kozasa K; Sumida I; Otani Y; Kimura T; Ogawa K
    Radiat Oncol; 2015 Aug; 10():180. PubMed ID: 26300325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.